SQUIRE PATTON BOGGS

Lobbying for ALPHYN BIOLOGICS · Clinical-stage dermatology co. developing first-in-class Multi-Target Therapeutics (MTT)

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · Senate · $30,000.00 income · posted Jan 13, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Advocacy work around Atopic Dermatitis (eczema).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.